Interleukins, Lymphokines and Lymphoid Neoplasia
As this volume clearly indicates, human cancer biology has recently focused to a large extent on the area of metastatic spread of tumor cells throughout the body. The delineation of biological consequences of such invasion to the host is for the first time beginning to be understood on more than a phenomenologic basis. Recent studies with a wide variety of experimental tumor systems, as reported here and in the literature, have begun to elucidate many of the biological mechanisms involved in the pathophysiology of neoplasia and have greatly improved our current understanding of the consequences of the spread of tumor cells. Another related area of emphasis has focused on the host’s immune system and its role in preventing the development of neoplasia through various putative immunosurveillance mechanisms available, or in suppressing the progression of the neoplastic process once the surveillance mechanism(s) are either interdicted or circumvented (1,2). This latter area is generally referred to as tumor immunology, dealing with the contest between the host’s immune system and the incipient or established tumor (usually of epithelial or mesenchymal origin). In this Chapter, we would like to discuss a related but somewhat more insidious condition, wherein the tumor is actually present within the host’s immune system. In such conditions of lymphoreticular neoplasia, one does not usually observe metastasis in the conventional sense.
KeywordsMigration Filtration Lymphoma Leukemia Agarose
Unable to display preview. Download preview PDF.
- 4.Crowther D, Wagstaff J: Lymphocyte migration in malignant disease. Clin. Exp. Immunol. 5: 413–420, 1983.Google Scholar
- 7.Maizel AL, Lachman L: Control of human lymphocyte proliferation by soluble factors. Lab. Invest. 50: 369–377, 1981.Google Scholar
- 8.Cohen S, Pick E, Oppenheim JJ: Biology of the Lymphokines. Academic Press, New York, 1979.Google Scholar
- 14.Lachman LB: Human Interleukin 1: Purification and properties. Fed. Proc. Fed. Am. Soc. Exp. Biol. 42: 2639–2645, 1983.Google Scholar
- 16.Oppenheim JJ, Stadler BM, Seraganian RP, Mage M, Mathieson B: Lymphokines: Their role in lymphocyte responses: Properties of interleukin 1. Fed. Proc. Fed. Am. Soc. Exp. Biol. 41: 258–265, 1981.Google Scholar
- 17.Ford RJ, Maizel AL: Immunobiology of lymphoreticular neoplasms. IN: Twomey JJ (ed.) The Pathophysiology of Human Immunologic Disorders. Urban and Schwartzenberg, Baltimore, pp. 199–217, 1982Google Scholar
- 19.Glicksman AS, Pajak TF: Early and late effects of lymphoma treatment in the expectation of cure. IN: Rosenberg SA and Kaplan HS (eds.) Malignant Lymphomas: Etiology, Immunology, Pathology, Treatment. Academic Press, New York, pp. 639–661, 1982.Google Scholar
- 21.Gallo RC, Mann D, Broder S, Ruscetti FW, Maeda M, Reitz MS: Human T cell leukemia-lymphoma virus (HTLV) is in T but not B lymphocytes from a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 79: 3680–3683, 1982.Google Scholar
- 22.Nilsson K: The nature of lymphoid cell lines and their relationship to the virus. IN: Epstein MA and Achong BG (eds.) The Epstein-Barr Virus. Springer-Verlag, New York, pp. 225–266, 1979.Google Scholar
- 29.Ford RJ: Unpublished observations.Google Scholar
- 40.Ford RJ, Tsao J, Kouttab N, Sahasrabuddhe CG, Mehta SR: Association of an Interleukin abnormality with the T cell defect in Hodgkin’s disease. Blood (In press).Google Scholar